Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Liberty Defense Announces Public Filing of Registration Statement for Proposed U.S. Initial Public Offering
-
Anathapindika Health Announces Placement in Three AlchePharma Stores
-
GraniteShares Announces Weekly Distributions for its YieldBOOST FoFs ETFs: YBST and YBTY
-
Solid Biosciences to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026
-
Mount Logan Capital Inc. Announces Final Results of Tender Offer
-
ESET’s Chief Security Evangelist Tony Anscombe to Speak at NetDiligence Cyber Risk Summit
-
Immutep Achieves 50% Enrolment in Global TACTI-004 (KEYNOTE-F91) Phase III Trial in 1L NSCLC
-
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Karat Packaging Board Declares Quarterly Cash Dividend
-
Hopebridge Announces Retirement of CEO Dennis May After a Decade of Leadership
-
Abercrombie & Fitch Co. to Report Fourth Quarter and Full Year 2025 Results on March 4, 2026
-
Smartkem Announces Significant Reduction in Accounts Payable Through Debt Conversion Agreement
-
Polyrizon Signs an Agreement to Develop Intranasal Proprietary Non-Hallucinogenic Neuroplastogen Formulation
-
Clearmind Medicine Enters into Development Agreement to Advance Intranasal Formulation for its Proprietary Non-Hallucinogenic Neuroplastogen MEAI
-
Jeffs’ Brands: KeepZone AI Announces Exclusive Agreement for the Reselling of Counter Underwater Systems for Drug Smuggling and Protecting Offshore Assets
-
Cambridge Acquisition Corp. Announces the Pricing of $200 Million Initial Public Offering
-
Plains All American Reports Fourth-Quarter and Full-Year 2025 Results
-
Wrap Technologies Highlights Clinton County Probation Services’ Adoption of WrapReality™ to Advance Non-Lethal Response Training in Corrections
-
Saga Metals Acknowledges U.S. Strategic Critical Minerals Reserve “Project Vault” and Highlights Titanium’s Strategic Importance to North American Defense Supply Chains
-
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Papa Johns Canada Launches Pizza My Heart for Valentine’s Day
-
TG Therapeutics Announces Presentation of Data for BRIUMVI® (ublituximab) in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum
-
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
AGF Management Limited - Normal Course Issuer Bid
-
AGF Investments Inc. Wins Seven 2025 Fundata FundGrade A+® Awards for Outstanding Fund Performance
-
Brixton Metals Defines New Exploration Targets at Thorn Through Geochemical Sampling
-
Enwex ERCOT Onshore Wind Futures Now Live for Trading on Abaxx Exchange
-
Dividend Declaration and Allotment Date Update
-
Dimensional Fund Advisors Ltd. : Form 8.3 - SPIRE HEALTHCARE GROUP PLC - Ordinary Shares
-
uniQure Announces Updated Preliminary AMT-191 Phase I/IIa Data Showing Sustained Increases in α-Gal A Enzyme Activity in Patients with Fabry Disease
-
Dimensional Fund Advisors Ltd. : Form 8.3 - NCC GROUP PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - JUST GROUP PLC - Ordinary Shares
-
Aktieselskabet Schouw & Co.: Summons for Written Resolution of Bondholders
-
Prime Drink Group Secures Exclusive North American Licenses for Beach Day Every Day
-
Dimensional Fund Advisors Ltd. : Form 8.3 - INTERNATIONAL PERSONAL FINAN - Ordinary Shares
-
Guardian Capital LP receives Fundata FundGrade A+® Award for 2025
-
Gencor Releases First Quarter Fiscal 2026 Results
-
From Early Morning Practices to Late-Night Drives: Kruger Products Champions Canada’s Hockey Parents in New Campaign, The Kruger Big Assist “Parent Assist”
-
Aurora Mobile’s EngageLab Partners with Blurams to Drive Global IoT Service Growth
-
Bitcoin Everlight Presale Progresses as Market Participants Revisit Bitcoin’s Early Network Phase
-
Roivant Announces Positive Phase 2 Results for Brepocitinib in Cutaneous Sarcoidosis (CS) and Reports Financial Results for the Third Quarter Ended December 31, 2025
-
Shoals Technologies Group, Inc. Announces Participation in Upcoming Events for the Investor Community
-
Immunovant Provides Corporate Updates and Reports Financial Results for the Third Quarter Ended December 31, 2025
-
Priovant Announces Positive Phase 2 Results for Brepocitinib in Cutaneous Sarcoidosis (CS)
-
Bitfarms Announces U.S. Redomiciliation Plan and Intent to Rebrand as Keel Infrastructure
-
Cibus Partnering with The John Innes Centre for UK Government’s Farming Innovation Programme Precision Breeding Initiative
-
Vine Hill Capital Investment Corp. II Announces the Separate Trading of Its Class A Ordinary Shares and Warrants, Commencing on February 9, 2026
-
Pulmovant Announces Completion of Enrollment in the Phase 2 PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)
-
Balchem Corporation Announces Quarterly Conference Call for Fourth Quarter and Full Year 2025 Financial Results on February 20, 2026
-
Coop Pank AS will hold an investor webinar to introduce the results for the fourth quarter and 12 month of 2025

